All In Biotech

Drug Trial Radar · NCT02223897

Mesenchymal Stem Cells Transplantation for Ischemic-type Biliary Lesions

Umbilical Cord Mesenchymal Stem Cells Transplantation for Treatment of Patients With Ischemic-type Biliary Lesions After Liver Transplantation

Last checked: Nov 19, 2026Latest source record: Aug 22, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

66

Planned (sponsor's estimate)

Start

Jul 2014

Primary completion

Jun 2017

Study completion Jun 2018

Sponsor

Lead sponsor
Yang YangAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Aug 22, 2014

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Prevention
Who can join
All sexes, from 18 years, up to 60 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Ischemic-type biliary lesions (ITBLs) are a major cause of graft loss and mortality after orthotopic liver transplantation (OLT). For now, there are still lacking effective treatment for ITBLs. The purpose of this study is to confirm whether human umbilical cord mesenchymal stem cells are effective in the treatment,or prevention of Ischemic-type Biliary Lesions after liver transplantation.

Conditions

  • Ischemic-type Biliary Lesions

Interventions

  • huc-MSCsDrug

    Received conventional treatment and huc-MSCs once per week for the first month and once per month for 6 months(9 times in total), at a dose of 1×106 huc-MSCs/kg body weight.

  • PlaceboDrug

    Received conventional treatment and 50 ml saline solution once per week for the first month and once per month for 6 months(9 times in total).

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The incidence of ITBLsTime frame: 18 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Third Affiliated Hospital, Sun Yat-Sen University

    Guangzhou, Guangdong, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.